case to trim or not to trim is the questi
Case To Trim Or Not To Trim: That Is The Question Themu had come up again and again in various menagement meetings and company sem na Novartie had too mary products and needed to reduce the product proliferation that had und Thomas Ebeling Cher Operating to Novartis Pharmaceutical wondered what he should do The merger of Chegy and Sandoz to form Novartis on December 20, 1998 had resulted na signatore in the pharmaceutical product portfolio of Novartis Pharma Sector Combring the pharmaceutical product lines of CooGegy and Sandoz had given Novartis a hadership position in several therapeutic areas including immunology and Informatory dis- as well as strong positions in central nervous systern disorders. cardiovascular disse oncology dermatology and authma. Novartis now had appreciately 250 product brands such Sandmmun Voeren Lamis and Ford). The sales volumes of each of the different brand however, were very hot in 1999, the top 20 brands accounted for 7 of pharmaceutical verus while the remaining brands yielded 21% of revenues, Novartis hot 1 presents sale, anticipated sales growth rates, cost and other data for me 50 smallest global base business brands that account for CHF 122 milion in sales for cromaty 2.7 of pharmaceutical products in 1998. In addition to the base buniness brandssted in Novartis Bebt 1, 15 other product brands contributed an additional CF 24 million in Although these products generated very rare, they satisfied some import medicale For sami, Viskenhede of CHF 114000 South Atria but was une among babockers regarding the chectonton Totors for the art of antidepresantion Novartis Exhubs costs to be and fand. Avec changes in proportion to go in the red level of actity of volume. Angle of cost is directed to make the products, wariable costs As soon al costs or pronics Abed costrins unchanged in to forgiven me porodice change in the of a tity or volume. Eames of the operating the plant and costs of chiggyanto matang products. In the longe dos tres bedsted to the of position values Comment on the best reported on 1. Andre Wala, Hodor Corp. COTT Dew Drodit of the products with Acurd 1 wline trade organe de creacity in our DIT Stofwiss wer pode ser boste Hugton even more duc caci con production and debution necount doh wa products Case To Trim Or Not To Trim: That Is The Question Themu had come up again and again in various menagement meetings and company sem na Novartie had too mary products and needed to reduce the product proliferation that had und Thomas Ebeling Cher Operating to Novartis Pharmaceutical wondered what he should do The merger of Chegy and Sandoz to form Novartis on December 20, 1998 had resulted na signatore in the pharmaceutical product portfolio of Novartis Pharma Sector Combring the pharmaceutical product lines of CooGegy and Sandoz had given Novartis a hadership position in several therapeutic areas including immunology and Informatory dis- as well as strong positions in central nervous systern disorders. cardiovascular disse oncology dermatology and authma. Novartis now had appreciately 250 product brands such Sandmmun Voeren Lamis and Ford). The sales volumes of each of the different brand however, were very hot in 1999, the top 20 brands accounted for 7 of pharmaceutical verus while the remaining brands yielded 21% of revenues, Novartis hot 1 presents sale, anticipated sales growth rates, cost and other data for me 50 smallest global base business brands that account for CHF 122 milion in sales for cromaty 2.7 of pharmaceutical products in 1998. In addition to the base buniness brandssted in Novartis Bebt 1, 15 other product brands contributed an additional CF 24 million in Although these products generated very rare, they satisfied some import medicale For sami, Viskenhede of CHF 114000 South Atria but was une among babockers regarding the chectonton Totors for the art of antidepresantion Novartis Exhubs costs to be and fand. Avec changes in proportion to go in the red level of actity of volume. Angle of cost is directed to make the products, wariable costs As soon al costs or pronics Abed costrins unchanged in to forgiven me porodice change in the of a tity or volume. Eames of the operating the plant and costs of chiggyanto matang products. In the longe dos tres bedsted to the of position values Comment on the best reported on 1. Andre Wala, Hodor Corp. COTT Dew Drodit of the products with Acurd 1 wline trade organe de creacity in our DIT Stofwiss wer pode ser boste Hugton even more duc caci con production and debution necount doh wa products
